Sequencing of protease inhibitor therapy: Insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors

Keyphrases

• Genetic Resistance 100%
• Protease Inhibitors 100%
• Protease Inhibitor Therapy 100%
• Nelfinavir 23%
• Cross-resistance 15%
• Indinavir 15%
• Reduced Susceptibility 15%
• Fold Increase 7%
• Virus 7%
• Antiretroviral Therapy 7%
• Metropolitan Areas 7%
• Antiretroviral 7%
• Drug Sensitivity 7%
• Treatment Regimen 7%
• HIV-infected Adults 7%
• HIV RNA 7%
• IC50 7%
• Amprenavir 7%
• Sectional Analysis 7%
• 50% Inhibitory Concentration 7%
• Magnitude of Change 7%
• Saquinavir 7%
• HIV-1 Susceptibility 7%
• HIV Clinics 7%

Medicine and Dentistry

• Human Immunodeficiency Virus 100%
• Proteinase Inhibitor 100%
• Nelfinavir 21%
• IC50 14%
• Indinavir 14%
• Cross Resistance 14%
• Antiretroviral Therapy 7%
• Cross Sectional Study 7%
• Saquinavir 7%
• Amprenavir 7%
• Virus 7%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Proteinase Inhibitor 100%
• Nelfinavir 21%
• IC50 14%
• Indinavir 14%
• Cross-Resistance 14%
• Amprenavir 7%
• Cross Sectional Study 7%
• Saquinavir 7%